Roles for inflammation and regulatory T cells in colon cancer

Toxicologic Pathology

Volumn 38, Issue 1, 2010, Pages 76-87

  Erdman, Susan E ^a   Poutahidis, Theofilos ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Colon cancer; Division of Comparative; Gut bacteria; Inflammation; TREG cells

Indexed keywords

APC PROTEIN; CD4 ANTIGEN; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; K RAS PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; RAG2 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BACTERIAL IMMUNITY; CANCER PREVENTION; CANCER RISK; CD4+ T LYMPHOCYTE; COLITIS; COLON CANCER; COLON CARCINOMA; COLORECTAL CANCER; DRUG EFFICACY; ENTERITIS; GASTROINTESTINAL INFECTION; HELICOBACTER HEPATICUS; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK REDUCTION; TH17 CELL; TUMOR IMMUNITY; ANIMAL; COLORECTAL TUMOR; DISEASE MODEL; INTESTINE; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINES; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 77952305365     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623309354110     Document Type: Review

References (81)

1. American Cancer Society (ACS). (2004). Cancer facts and figures. U.S. Cancer Fact and Figures. ACS, Atlanta, GA.
2. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995-1004.
3. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., and Weiner, H. L. (2007). A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat Immunol 8, 1380-1389
4. Badache, A., and Hynes, N. E. (2001). Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res 61, 383-391
5. Balkwill, F., and Coussens, L. M. (2001). Cancer: An inflammatory link. Nature 431, 405-406
6. Balkwill, F., and Mantovani, A. (2001). Inflammation and cancer: Back to Virchow? Lancet 357, 539-545
7. Balkwill, F., Charles, K. A., and Mantovani, A. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217
8. Baltgalvis, K. A., Berger, F. G., Pena, M. M., Davis, J. M., Muga, S. J., and Carson, J. A. (2008). Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol 294, R393-401.
9. Belkaid, Y., and Rouse, B. T. (2005). Natural regulatory T cells in infectious disease. Nat Immunol 6, 353-360
10. Berishaj, M., Gao, S. P., Ahmed, S., Leslie, K., Al-Ahmadie, H., Gerald, W. L., Bornmann, W., and Bromberg, J. F. (2007). Stat3 is tyrosinephosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res 9, R32.
11. Bettelli, E., and Kuchroo, V. K. (2007). IL-12- and IL-23-induced T helper cell subsets: Birds of the same feather flock together. J Exp Med 201, 169-171
12. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., and Kuchroo, V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238
13. Bettelli, E., Korn, T., and Kuchroo, V. K. (2007). Th17: The third member of the effector T cell trilogy. Curr Opin Immunol 19, 652-657
14. Bettelli, E., Oukka, M., and Kuchroo, V. K. (2007). T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8, 345-350
15. Boivin, G. P., Washington, K., Yang, K., Ward, J. M., Pretlow, T. P., Russell, R., Besselsen, D. G., Godfrey, V. L., Doetschman, T., Dove, W. F., Pitot, H. C., Halberg, R. B., Itzkowitz, S. H., Groden, J., and Coffey, R. J. (2003). Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 124, 762-777
16. Bromberg, J., and Wang, T. C. (2009). Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15, 79-80.
17. Burch, J. C., Byrd, B. F., and Vaughn, W. K. (1975). The effects of long-term estrogen administration to women following hysterectomy. Front Horm Res 3, 208-214
18. Chow, J., and Mazmanian, S. K. (2009). Getting the bugs out of the immunesystem: Do bacterial microbiota "fix" intestinal T cell responses? Cell Host Microbe 5, 8-12.
19. Colombo, M. P., and Piconese, S. (2007). Regulatory-T-cell inhibition versus depletion: The right choice in cancer immunotherapy. Nat Rev Cancer 7, 880-887
20. Correa, P. (2003). Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 12, 238s-41s.
21. Coussens, L. M., and Werb, Z. (1999). Inflammation and cancer. Nature 420, 860-867
22. Crawford, J. M. (1999). The gastrointestinal tract. In Robbins Pathological Basis of Disease (), pp.. WB Saunders, Philadelphia.
23. Curiel, T. J. (2008). Regulatory T cells and treatment of cancer. Curr Opin Immunol 20, 241-246
24. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., and Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10, 942-949
25. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., and Mauri, C. (2004). Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200, 277-285
26. El-Omar, E. M., and Malfertheiner, P. (2001). Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol 17.
27. Engle, S. J., Ormsby, I., Pawlowski, S., Boivin, G. P., Croft, J., Balish, E., and Doetschman, T. (2002). Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 62, 6362-6366
28. Erdman, S. E., Fox, J. G., Sheppard, B. J., Feldman, D., and Horwitz, B. H. (2001). Regulatory T cells prevent non-B non-T colitis. Gastroenterology 120(Suppl 1), A524.
29. Erdman, S. E., Poutahidis, T., Tomczak,M., Rogers, A. B., Cormier, K., Plank, B., Horwitz, B. H., and Fox, J. G. (2003). CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 162, 691-702.
30. Erdman, S. E., Rao, V. P., Poutahidis, T., Ihrig, M. M., Ge, Z., Feng, Y., Tomczak, M., Rogers, A. B., Horwitz, B.H., and Fox, J. G. (2003). CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 63, 6042-6050
31. Erdman, S. E., Rao, V. P., Poutahidis, T., Rogers, A. B., Taylor, C. L., Jackson, E. A., Ge, Z., Lee, C. W., Schauer, D. B., Wogan, G. N., Tannenbaum, S. R., and Fox, J. G. (2009). Nitric oxide and TNF-a trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A 106, 1027-1032
32. Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., and Schauer, D. B. (2005). CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 65, 3998-4004.
33. Faubion, W. A., De Jong, Y. P., Molina, A. A., Ji, H., Clarke, K., Wang, B., Mizoguchi, E., Simpson, S. J., Bhan, A. K., and Terhorst, C. (2004). Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery. Gastroenterology 126, 1759-1770
34. Fearon, E. R., and Vogelstein, B. (1990). A genetic model for colorectal tumorigenesis. Cell 61, 759-767
35. Fox, J. G., and Wang, T. C. (2007). Inflammation, atrophy, and gastric cancer. J Clin Invest 117, 60-69.
36. Fox, J. G., Beck, P., Dangler, C. A.,Whary, M. T.,Wang, T. C., Shi, H. N., and Nagler-Anderson, C. (2000). Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6, 536-542
37. Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., Rao, V. P., Poutahidis, T., Weissleder, R., McNagny, K. M., and Khazaie, K. (2007). Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A 104, 19977-19982
38. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F., and Karin, M. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296
39. Kado, S., Uchida, K., Funabashi, H., Iwata, S., Nagata, Y., Ando, M., Onoue, M., Matsuoka. Y., Ohwaki, M., and Morotomi, M. (2001). Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 61, 2395-2398
40. Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-436
41. Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B., and Glaser, R. (2003). Chronic stress and age-related increases in the pro-inflammatory cytokine IL-6. Proc Natl Acad Sci U S A 100, 9090-9095
42. Kobaek-Larsen, M., Thorup, I., Diederichsen, A., Fenger, C., and Hoitinga, M. R. (2000). Review of colorectal cancer and its metastases in rodent models: Comparative aspects with those in humans. Comp Med 50, 16-26.
43. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M., and Joosten, I. (2008). Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340-2352
44. Korn, T., Oukka, M., Kuchroo, V., and Bettelli, E. (2007). Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 19, 362-371
45. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., Oukka, M., and Kuchroo, V. K. (2007). Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13, 423-431
46. Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J., Powrie, F., Cheever, A. W., Maloy, K. J., and Sher, A. IL-23 plays a key role in Helicobacter hepaticus-induced T celldependent colitis. J Exp Med 203, 2485-2494
47. Kullberg, M. C., Jankovic, D., Gorelick, P. L., Caspar, P., Letterio, J. J., Cheever, A. W., and Sher, A. (2002). Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196, 505-515
48. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., and Attali, P. (1991). Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101, 635-639
49. Lewis, C. E., and Pollard, J. W. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66, 605-612
50. Ley, C., and Parsonnet, J. (2000). Gastric adenocarcinoma. In Infectious Causes of Cancer (J. J. Goedert, ed.), pp. 389-410. Humana Press, Totowa, NJ.
51. Lin, J., Zhang, S. M., Cook, N. R., Manson, J. E., Buring, J. E., and Lee, I. M. (2007). Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 165, 794-801.
52. Lin, M. T., Juan, C. Y., Chang, K. J., Chen, W. J., and Kuo, M. L. (2001). IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1. Carcinogenesis 22, 1947-1953
53. Maloy, K. J., Salaun, L., Cahill, R., Dougan, G., Saunders, N. J., and Powrie, F. (2003). CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197, 111-119
54. Marnett, L. J., and DuBois, R. N. (2002). COX-2: A target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42, 55-80.
55. Mazmanian, S. K., Round, J. L., and Kasper, D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625
56. Meagher, M. W., Johnson, R. R., Vichaya, E. G., Young, E. E., Lunt, S., and Welsh, C. J. (2007). Social conflict exacerbates an animal model of multiple sclerosis. Trauma Violence Abuse 8, 314-330
57. Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., and Blay, J. Y. (1998). Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778-4791
58. Moser, A. R., Pitot, H. C., and Dove, W. F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324
59. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., and Karin, M. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124
60. Pace, T. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, A. H., and Heim, C. M. (2006). Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163, 1630-1633
61. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., and Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325, 1127-1131
62. Peek, R. M., Jr., and Blaser, M. J. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2, 28-37.
63. Pereg, D., and Lishner, M. (2005). Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med 258, 115-123
64. Pollard, J. W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4, 71-78.
65. Poutahidis, T., Haigis, K. M., Rao, V. P., Nambiar, P. R., Taylor, C. L., Ge, Z., Watanabe, K., Davidson, A., Horwitz, B. H., Fox, J. G., and Erdman, S. E. (2007). Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis 28, 2614-2623
66. Poutahidis, T., Rao, V. P., Olipitz,W., Taylor, C. L., Jackson, E. A., Levkovich, T., Lee, C. W., Fox, J. G., Ge, Z., and Erdman, S. E. (2009). CD4+ lymphocytes modulate prostate cancer progression in mice. Int J Cancer.
67. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237
68. Powrie, F., and Maloy, K. J. (2003). Immunology. Regulating the regulators. Science 299, 1030-1031
69. Radhakrishnan, S., Cabrera, R., Schenk, E. L., Nava-Parada, P., Bell, M. P., Van Keulen, V. P., Marler, R. J., Felts, S. J., and Pease, L. R. (2008). Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol 181, 3137-3147
70. Rao, V. P., Poutahidis, T., Fox, J. G., and Erdman, S. E. (2007). Breast cancer: Should gastrointestinal bacteria be on our radar screen? Cancer Res 67, 847-850
71. Rao, V. P., Poutahidis, T., Ge, Z., Nambiar, P. R., Boussahmain, C., Wang, Y. Y., Horwitz, B. H., Fox, J. G., and Erdman, S. E. (2006). Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 66, 7395-7400.
72. Rao, V. P., Poutahidis, T., Ge, Z., Nambiar, P. R., Horwitz, B. H., Fox, J. G., and Erdman, S. E. (2006). Pro-inflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 66, 57-61.
73. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., Morson, B. C., et al. (1983). Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14, 931-968
74. Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C.,and Iacopetta, B. (2009). Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27, 186-192
75. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M., Stewart, V., Mendelsohn, M., Charron, J., Datta, M., Young, F., Stall, A. M., et al. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867
76. Waddell, W. R., Gerner, R. E., and Reich, M. P. (1983). Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach. J Surg Oncol 22, 197-211.
77. Ward, J. M., Anver, M. R., Haines, D. C., and Benveniste, R. E. (1994). Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145, 959-968
78. Ward, J. M., Anver, M. R., Haines, D. C., Melhorn, J. M., Gorelick, P., Yan, L., and Fox, J. G. (1996). Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 46, 15-20.
79. Weiss, S. T. (2002). Eat dirt-the hygiene hypothesis and allergic diseases. N Engl J Med 347, 930-931
80. Williams, M. P., and Pounder, R. E. (1999). Helicobacter pylori: From the benign to the malignant. Am J Gastroenterol 94 (), S11-16.
81. Wills-Karp, M., Santeliz, J., and Karp, C. L. (2001). The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 1, 69-75.